Primus Pharmaceuticals Competitors, Revenue, Alternatives and Pricing

Claim your profile


Phoenix, AZ USA
Total Funding:N/A
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Primus Pharmaceuticals's estimated annual revenue is currently $25.3M per year.(?)
  • Primus Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Primus Pharmaceuticals has 126 Employees.(?)
  • Primus Pharmaceuticals currently has 1 job openings.

Primus is a market-driven, specialty pharmaceutical company dedicated to improving patient quality of life without compromising safety. Our purpose is to become the leader in first-line metabolic therapies by developing prescription products to restore metabolic processes which underlie diseases, rather than merely masking symptoms. Our formulation utilize patented nutritional ingredients in products that are regulated as medical foods. Medical foods have been historically distributed through hospital pharmacies, while we distribute through retail pharmacies. Primus also offers prescription drug products that improve the delivery of established compounds. Our products play an important role in the safe daily dietary management of chronic or recurring diseases and their associated metabolic aspects. Our products have exceptional safety profiles: They begin with Generally Recognized As Safe (GRAS) nutritional ingredients or, as do all medical foods. But in addition, 1) these GRAS ingredients have decades or centuries of safe use, including in other countries; and 2) the formula that became Limbrel was studied (via toxicity tests, animal studies and human trials) for approximately 7 years pre-market. Primus is privately held, and based in Scottsdale, Arizona.